Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial

समान संसाधन

• SU14. Characteristics Associated With Relapse in Patients With Schizophrenia: Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Cariprazine Relapse Prevention Trial
  द्वारा: Kunovac, Jelena, और अन्य
  प्रकाशित: (2017)
• Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies
  द्वारा: Earley, Willie, और अन्य
  प्रकाशित: (2017)
• Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial
  द्वारा: Earley, Willie R., और अन्य
  प्रकाशित: (2018)
• Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis
  द्वारा: Durgam, Suresh, और अन्य
  प्रकाशित: (2017)
• Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
  द्वारा: Vieta, Eduard, और अन्य
  प्रकाशित: (2019)